NFKB1 and cancer: Recent studies have discovered a new drug that can inhibit NF‐κB by targeting the IκB kinase, thereby improving myocardial atrophy caused by tumor cachexia,128 but some differences in mechanism between cardiac and skeletal muscle wasting caused by cancer cachexia have been found.